Growth Metrics

Quest Diagnostics (DGX) Cash from Financing Activities: 2009-2025

Historic Cash from Financing Activities for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to -$247.0 million.

  • Quest Diagnostics' Cash from Financing Activities fell 113.95% to -$247.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 191.84%. This contributed to the annual value of $1.1 billion for FY2024, which is 577.50% up from last year.
  • Latest data reveals that Quest Diagnostics reported Cash from Financing Activities of -$247.0 million as of Q3 2025, which was up 15.70% from -$293.0 million recorded in Q2 2025.
  • Quest Diagnostics' Cash from Financing Activities' 5-year high stood at $1.8 billion during Q3 2024, with a 5-year trough of -$1.6 billion in Q2 2021.
  • In the last 3 years, Quest Diagnostics' Cash from Financing Activities had a median value of -$153.0 million in 2024 and averaged $13.0 million.
  • Per our database at Business Quant, Quest Diagnostics' Cash from Financing Activities plummeted by 1,147.37% in 2022 and then skyrocketed by 2,232.53% in 2024.
  • Over the past 5 years, Quest Diagnostics' Cash from Financing Activities (Quarterly) stood at -$369.0 million in 2021, then tumbled by 47.70% to -$545.0 million in 2022, then spiked by 123.85% to $130.0 million in 2023, then crashed by 230.77% to -$170.0 million in 2024, then plummeted by 113.95% to -$247.0 million in 2025.
  • Its last three reported values are -$247.0 million in Q3 2025, -$293.0 million for Q2 2025, and -$561.0 million during Q1 2025.